Anti-ageing glycoprotein promotes long-term survival of transplanted neurosensory precursor cells
Open Access
- 27 May 2016
- journal article
- research article
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (9) , 2658-2662
Abstract
Cell therapy, to replace lost tissue, is a promising approach for the treatment of various neurodegenerative diseases. Many studies suggest, however, that the percentage of transplanted cells that survive and undergo functional integration remains low as a result of immune rejection, suboptimal precursor cell type, trauma during cell transplantation, toxic compounds released by dying tissues or nutritional deficiencies. We recently developed an ex vivo system to facilitate identification of factors contributing to the death of transplanted neuronal (photoreceptor) cells and compounds that block these toxic effects. In this system, photoreceptor precursor cells (PPCs) are sandwiched between a neurosensory retinal explant and retinal pigment epithelium derived from human embryonic stem cells. Explant medium was collected to identify toxic components and PPC survival was assessed by flow cytometry. We also assessed the potential for AAGP™, a cryopreservative molecule, to improve PPC survival. We identified elevated prostaglandin E2 (PGE2) in the explant medium and demonstrated that AAGP™ reduced PGE2 levels by 2.6-fold. A pro-inflammatory stress assay suggested that this may result from AAGP™ inhibition of cyclo-oxygenase-2 (COX-2) expression. We confirmed that PGE2 reduced the viability of cultured PPCs by 44% and found that the survival rate of PPCs pretreated with AAGP™ was 2.8-fold higher than in untreated PPCs. These data suggest that PGE2 release from necrotic tissue may be one factor that reduces the survival of transplanted precursor cells and that the pro-survival molecule AAGP™ may improve long-term transplanted cell viability. Copyright © 2016 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Neural Repair and Neuroprotection with Stem Cells in Ischemic StrokeBrain Sciences, 2013
- Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantationProceedings of the National Academy of Sciences, 2013
- Defining the Integration Capacity of Embryonic Stem Cell-Derived Photoreceptor PrecursorsStem Cells, 2012
- TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory eventsJournal of Experimental Medicine, 2008
- Cell Transplantation Therapy for StrokeStroke, 2007
- A2E Selectively Induces COX-2 in ARPE-19 and Human Neural CellsCurrent Eye Research, 2006
- Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neuronsNeurochemistry International, 2004
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002
- ATP-stimulated Release of Interleukin (IL)-1β and IL-18 Requires Priming by Lipopolysaccharide and Is Independent of Caspase-1 CleavageJournal of Biological Chemistry, 2001
- ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated PropertiesExperimental Eye Research, 1996